TAXOL Safety Questions, TAXOL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about TAXOL. Our extensive database of TAXOL adverse events and TAXOL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about TAXOL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




TAXOL Safety Reports

Total TAXOL reports: 493.
TAXOL FDA safety alerts: No.
Reported deaths: 97    Reported hospitalizations: 219.
Take TAXOL Side Effects Survey or Share Your TAXOL Story. TAXOL Usage.

Showing 1-75 of 493 Next >

Physician from UNITED STATES reported TAXOL problem on Apr 11, 2006. Female patient, 49 years of age, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: pneumonia. TAXOL dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2006. Female patient, 52 years of age, weighting 271.2 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: convulsion, urticaria. TAXOL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Mar 27, 2006. Female patient, weighting 169.8 lb, was diagnosed with endometrial cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: anal fissure, constipation, haemorrhoids. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN, BENADRYL, LIPITOR, ASPIRIN, MAGNESIUM CITRATE. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2006. Male patient, 88 years of age, weighting 160.9 lb, was diagnosed with prostate cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: catheter related complication. TAXOL dosage: unknown. During the same period patient was treated with TAGAMET, BENADRYL, KYTRIL, DECADRON, FLOMAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Mar 28, 2006. Male patient, 75 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: extravasation. TAXOL dosage: unknown. During the same period patient was treated with ZOFRAN, ZANTAC, DECADRON. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2006. Female patient, weighting 185.2 lb, was diagnosed with breast cancer, upper respiratory tract infection, palmar-plantar erythrodysaesthesia syndrome and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: palmar-plantar erythrodysaesthesia syndrome. TAXOL dosage: unknown. During the same period patient was treated with DECADRON, BENADRYL, TAGAMET, ANZEMET, TYLENOL, AUGMENTIN, NEULASTA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Apr 19, 2006. Female patient, 71 years of age, weighting 141.1 lb, was diagnosed with angiosarcoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia. TAXOL dosage: unknown. Patient recovered.

TAXOL problem was reported by a Physician from UNITED STATES on June 29, 2006. Female patient, 81 years of age, weighting 130.1 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: arthralgia, atrioventricular block complete, myalgia. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN, HERCEPTIN, DECADRON, ATENOLOL, DYAZIDE, NEXIUM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on May 03, 2006. Female patient, 48 years of age, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: dehydration, dizziness, hypoaesthesia oral. TAXOL dosage: unknown. During the same period patient was treated with TAGAMET, BENADRYL, DECADRON. Patient was hospitalized. Patient recovered.

TAXOL problem was reported by a Health Professional from UNITED STATES on June 12, 2006. Female patient, 51 years of age, was diagnosed with cervix carcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. TAXOL dosage: unknown. During the same period patient was treated with DECADRON, BENADRYL, PEPCID, DURAGESIC. Patient died on 02/02/2006.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on May 12, 2006. Female patient, weighting 160.9 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: neuropathy. TAXOL dosage: unknown. During the same period patient was treated with BENADRYL, COMPAZINE, ATIVAN, PAMELOR, AMBIEN, PREVACID, ZELNORM, CORGARD. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on May 19, 2006. Male patient, 58 years of age, weighting 194.0 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: extravasation. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN, DEXAMETHASONE, BENADRYL, PEPCID, COMPAZINE, ZOFRAN, ASPIRIN, HYDROCHLOROTHIAZIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Mar 01, 2006. Female patient, 27 years of age, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, gastrointestinal pain, pruritus, tachycardia. TAXOL dosage: unknown. During the same period patient was treated with BENADRYL, PEPCID, KYTRIL, ATIVAN, DEXAMETHASONE. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2006. Female patient, 64 years of age, weighting 169.8 lb, was diagnosed with ovarian cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: erythema, nail disorder, skin disorder. TAXOL dosage: unknown. During the same period patient was treated with PRANDIN, SYNTHROID, COZAAR, LOMOTIL, LEXAPRO, ZOFRAN, ATIVAN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on June 27, 2006. Male patient, 69 years of age, was diagnosed with lung neoplasm malignant, laryngeal cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: extravasation. TAXOL dosage: unknown. During the same period patient was treated with ALOXI, DECADRON, CARBOPLATIN. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on June 01, 2006. Female patient, 52 years of age, weighting 152.1 lb, was diagnosed with breast cancer stage iv and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: hypotrichosis. TAXOL dosage: unknown. During the same period patient was treated with AVASTIN, SYNTHROID, CELEBREX, DEXAMETHASONE, BENADRYL, ZOFRAN, PEPCID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on June 20, 2006. Female patient, 51 years of age, weighting 169.8 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: anaemia, dyspnoea, epistaxis, nail discolouration, onychoclasis, pruritus, rash, rectal haemorrhage, swelling. TAXOL dosage: unknown. During the same period patient was treated with HERCEPTIN, SERZONE, BENADRYL, PREDNISONE, ZANTAC. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on June 22, 2006. Female patient, 44 years of age, weighting 165.3 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: neuropathy. TAXOL dosage: unknown. During the same period patient was treated with DILAUDID, ATIVAN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on July 18, 2006. Male patient, 51 years of age, was diagnosed with lung neoplasm malignant and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. TAXOL dosage: unknown. During the same period patient was treated with ZOFRAN, DECADRON, CARBOPLATIN. Patient died on 04/20/2006.

TAXOL problem was reported by a Health Professional from UNITED STATES on June 27, 2006. Male patient, 62 years of age, weighting 205.0 lb, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. TAXOL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on July 06, 2006. Female patient, weighting 167.6 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: rash, white blood cell count decreased. TAXOL dosage: unknown. During the same period patient was treated with DECADRON, BENADRYL, CIMETIDINE, SYNTHROID, ASPIRIN, TYLENOL, ARANESP, ZOFRAN. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on July 07, 2006. Female patient, 56 years of age, weighting 169.8 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: dysacusis, vision blurred. TAXOL dosage: unknown. During the same period patient was treated with HERCEPTIN, DECADRON. Patient recovered.

Health Professional from UNITED STATES reported TAXOL problem on July 14, 2006. Male patient, 73 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, fatigue, lobar pneumonia, oedema peripheral, pulmonary toxicity. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2006. Female patient, 46 years of age, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: infusion related reaction. TAXOL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on July 24, 2006. Female patient, 36 years of age, weighting 136.7 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: meningitis. TAXOL dosage: unknown. During the same period patient was treated with PHENERGAN, VICODIN, COMPAZINE, DECADRON, EPOGEN, IRON SUCROSE. Patient was hospitalized. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2006. Female patient, 60 years of age, was diagnosed with ovarian cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN, BENADRYL, ANZEMET, DECADRON. Patient was hospitalized. Patient died on 07/15/2006.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Aug 11, 2006. Female patient, weighting 163.1 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased. TAXOL dosage: unknown. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2006. Female patient, weighting 152.1 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: neuropathy. TAXOL dosage: unknown. During the same period patient was treated with AVASTIN, ASCORBIC ACID, MOTRIN, COMPAZINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Apr 19, 2006. Female patient, 80 years of age, was diagnosed with angiosarcoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia. TAXOL dosage: unknown. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Female patient, 59 years of age, weighting 185.2 lb, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: back pain, chest discomfort, flushing, rash. TAXOL dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Health Professional from UNITED STATES reported TAXOL problem on Aug 28, 2006. Female patient, 36 years of age, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: pyrexia. TAXOL dosage: unknown. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2006. Female patient, 41 years of age, weighting 160.9 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: paraesthesia. TAXOL dosage: unknown. During the same period patient was treated with ASACOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Oct 03, 2006. Male patient, 48 years of age, was diagnosed with lung neoplasm malignant and was treated with TAXOL. TAXOL dosage: unknown. Patient died on 09/04/2006.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2006. Female patient, 53 years of age, weighting 121.3 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal. TAXOL dosage: unknown. During the same period patient was treated with PULMICORT, NEXIUM, ALPRAZOLAM. Patient recovered.

Pharmacist from UNITED STATES reported TAXOL problem on Dec 05, 2006. Male patient, 79 years of age, weighting 187.4 lb, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: chest pain, paraesthesia. TAXOL dosage: unknown. During the same period patient was treated with DECADRON, PEPCID, ZOFRAN, MANNITOL, BENADRYL, ASPIRIN. Patient was hospitalized. Patient recovered.

TAXOL problem was reported by a Pharmacist from UNITED STATES on Oct 18, 2006. Male patient, 46 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: dizziness, flushing, nausea, vomiting. TAXOL dosage: unknown. During the same period patient was treated with DECADRON, ZOFRAN, BENADRYL, PEPCID. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Dec 05, 2006. Female patient, 84 years of age, weighting 112.4 lb, was diagnosed with uterine cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: dyspnoea. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN, DECADRON, ZOFRAN, PEPCID, ATIVAN, ASPIRIN, PLAVIX, NITROGLYCERIN. Patient was hospitalized. Patient recovered.

TAXOL problem was reported by a Pharmacist from UNITED STATES on Dec 05, 2006. Female patient, 30 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: dyspnoea. TAXOL dosage: unknown. During the same period patient was treated with DECADRON, ZOFRAN, BENADRYL, NARCAN, ROCEPHIN, VANCOMYCIN HYDROCHLORIDE, GENTAMICIN, ZOSYN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Oct 31, 2006. Female patient, 70 years of age, weighting 125.7 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, paraesthesia. TAXOL dosage: unknown. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2006. Female patient, 69 years of age, was diagnosed with uterine cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: back pain, palpitations. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Physician from UNITED STATES reported TAXOL problem on Nov 07, 2006. Female patient, 58 years of age, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: arthralgia. TAXOL dosage: unknown. During the same period patient was treated with TAMOXIFEN CITRATE. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2006. Male patient, 68 years of age, was diagnosed with neoplasm malignant and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: extravasation. TAXOL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Dec 14, 2006. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with lung neoplasm malignant and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: back pain. TAXOL dosage: unknown. During the same period patient was treated with FAMOTIDINE, DEXAMETHASONE, BENADRYL, AVASTIN. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2006. Male patient, 82 years of age, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: alopecia. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Health Professional from JAPAN reported TAXOL problem on Feb 21, 2007. Female patient, 57 years of age, was diagnosed with uterine cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, neuropathy peripheral, neutrophil count decreased, retinopathy, thrombocytopenia. TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, AMARYL, DEXAMETHASONE, DIPHENHYDRAMINE, RANITIDINE. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from ITALY on Feb 21, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. TAXOL dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAXOL problem on Feb 21, 2007. Female patient, 74 years of age, was diagnosed with ovarian cancer, hypertension, neuropathy peripheral, gastritis, diabetes mellitus non-insulin-dependent and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, arthralgia, disseminated intravascular coagulation, neuropathy peripheral, staphylococcal sepsis. TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, NORVASC, KINEDAK, CYANOCOBALAMIN, GASTER, FASTIC. Patient died on 12/04/2006.

TAXOL problem was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation. TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, SORAFENIB, DECADRON, RESTAMIN, ZANTAC, KYTRIL, VOLTAREN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAXOL problem on Feb 20, 2007. Female patient, 78 years of age, was diagnosed with ovarian cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient recovered.

TAXOL problem was reported by a Health Professional from UNITED STATES on Mar 01, 2007. Male patient, 64 years of age, weighting 172.0 lb, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, coronary artery occlusion, stent occlusion, thrombosis. TAXOL dosage: unknown. Patient recovered.

Consumer or non-health professional from INDIA reported TAXOL problem on Feb 21, 2007. Male patient, 48 years of age, was diagnosed with neoplasm malignant and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: asthenia, sepsis. TAXOL dosage: unknown. Patient died.

TAXOL problem was reported by a Health Professional from FRANCE on Feb 26, 2007. Female patient, 46 years of age, was diagnosed with breast cancer, anxiety and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: macular oedema, visual acuity reduced. TAXOL dosage: unknown. During the same period patient was treated with PAROXETINE, XANAX. Patient recovered.

Health Professional from JAPAN reported TAXOL problem on Feb 22, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: oesophagitis. TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient recovered.

TAXOL problem was reported by a Health Professional from JAPAN on Feb 22, 2007. Male patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: oesophagitis. TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient recovered.

Health Professional from JAPAN reported TAXOL problem on Feb 20, 2007. Male patient, 75 years of age, was diagnosed with transitional cell carcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal necrosis. TAXOL dosage: unknown. During the same period patient was treated with GEMZAR. Patient died.

TAXOL problem was reported by a Physician from FRANCE on Feb 28, 2007. Female patient, 78 years of age, was diagnosed with lung neoplasm malignant, hypertension, hypercholesterolaemia and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: arthralgia, diarrhoea, febrile neutropenia, flushing, myalgia, neuropathy, pyrexia. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN, PREDNISONE, POLARAMINE, CLARITIN, SECTRAL, ALDACTONE, FENOFIBRATE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported TAXOL problem on Mar 05, 2007. Male patient, 83 years of age, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: medical device complication. TAXOL dosage: unknown. Patient recovered.

TAXOL problem was reported by a Health Professional from JAPAN on Mar 02, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: anorexia, vomiting. TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient was hospitalized. Patient recovered.

Health Professional from JAPAN reported TAXOL problem on Mar 07, 2007. Female patient, 43 years of age, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: diarrhoea, haematochezia, melaena. TAXOL dosage: unknown. During the same period patient was treated with XELODA, FARESTON, PRIMPERAN, GASTER, KYTRIL, DECADRON, RINDERON. Patient was hospitalized. Patient recovered.

TAXOL problem was reported by a Pharmacist from UNITED STATES on Mar 09, 2007. Male patient, weighting 192.9 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: back pain, blood pressure increased, chest pain, dyspnoea, feeling hot, flushing, heart rate increased, infusion related reaction, oxygen saturation decreased. TAXOL dosage: 90MG WEEKLY IV DRIP. Patient recovered.

Physician from JAPAN reported TAXOL problem on Mar 07, 2007. Male patient, 82 years of age, was diagnosed with pancreatic carcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: upper gastrointestinal haemorrhage. TAXOL dosage: unknown. During the same period patient was treated with TRIMETHOPRIM, WARFARIN POTASSIUM, RANDA, FLUOROURACIL. Patient died on 12/01/2004.

TAXOL problem was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, 66 years of age, was diagnosed with uterine cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: duodenal perforation. TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, ADRIAMYCIN PFS. Patient died on 12/25/2006.

Consumer or non-health professional from UNITED STATES reported TAXOL problem on Mar 08, 2007. Male patient, 56 years of age, weighting 167.6 lb, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: dehydration. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN, OXYCONTIN, PHENERGAN, XANAX, ADVAIR DISKUS, PERCOCET, SPIRIVA. Patient was hospitalized. Patient recovered.

TAXOL problem was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, 45 years of age, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: photosensitivity reaction. TAXOL dosage: unknown. During the same period patient was treated with DEXAMETHASONE PHOSPHATE, RANITIDINE, GRANISETRON, DIPHENHYDRAMINE. Patient recovered.

Physician from JAPAN reported TAXOL problem on Mar 08, 2007. Female patient, 77 years of age, was diagnosed with lung adenocarcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiac failure congestive, disseminated intravascular coagulation, pulmonary embolism. TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, DECADRON, ZOFRAN ZYDIS, PRIMPERAN, ZANTAC, NASEA. Patient was hospitalized and became disabled. Patient recovered.

TAXOL problem was reported by a Health Professional from JAPAN on Mar 13, 2007. Female patient, 43 years of age, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: diarrhoea, haematochezia, melaena. TAXOL dosage: unknown. During the same period patient was treated with XELODA, PRIMPERAN, GASTER, KYTRIL, DECADRON, RINDERON, HUMULIN. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported TAXOL problem on Mar 09, 2007. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: nausea, paraesthesia, vertigo. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient died.

TAXOL problem was reported by a Health Professional from GERMANY on Mar 09, 2007. Female patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: anorexia, dyspnoea, malignant neoplasm progression, polyneuropathy. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient died on 10/01/2003.

Health Professional from GERMANY reported TAXOL problem on Mar 09, 2007. Female patient, 67 years of age, was diagnosed with ovarian cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: cough, diarrhoea, malignant neoplasm progression, sensory disturbance. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient died on 02/01/2003.

TAXOL problem was reported by a Health Professional from FRANCE on Mar 09, 2007. Male patient, 69 years of age, weighting 156.5 lb, was diagnosed with lung neoplasm and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: dysphonia, speech disorder. TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN, SOLUPRED, LOVENOX, VASTAREL, KARDEGIC. Patient was hospitalized. Patient recovered.

Health Professional from JAPAN reported TAXOL problem on Mar 12, 2007. Female patient, 55 years of age, was diagnosed with ovarian cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: hypocalcaemia, hypomagnesaemia. TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, TAXOTERE. Patient was hospitalized. Patient recovered.

TAXOL problem was reported by a Health Professional from JAPAN on Mar 12, 2007. Male patient, 75 years of age, was diagnosed with transitional cell carcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: intestinal ischaemia. TAXOL dosage: unknown. During the same period patient was treated with GEMZAR. Patient died on 12/24/2005.

Physician from UNITED STATES reported TAXOL problem on Mar 16, 2007. Male patient, weighting 290.0 lb, was diagnosed with myocardial infarction and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: post procedural myocardial infarction, postoperative thrombosis. TAXOL dosage: unknown. Patient recovered.

TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2007. Female patient, 42 years of age, weighting 147.7 lb, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: myelitis, peripheral motor neuropathy, peripheral sensory neuropathy. TAXOL dosage: unknown. During the same period patient was treated with EPIRUBICIN. Patient recovered.

Physician from JAPAN reported TAXOL problem on Mar 22, 2007. Male patient, 82 years of age, was diagnosed with pancreatic carcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: upper gastrointestinal haemorrhage. TAXOL dosage: unknown. During the same period patient was treated with TRIMETHOPRIM, WARFARIN POTASSIUM, RANDA, FLUOROURACIL. Patient died on 12/01/2004.

Showing 1-75 of 493 Next >

Ask Our Patient Community about TAXOL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
Osmop